Galectin Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Galectin Therapeutics by Citigroup
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $18k | 11k | 1.66 |
2021-03-31 | $5.0k | 2.5k | 2.03 |
2020-12-31 | $17k | 7.5k | 2.28 |
2020-09-30 | $5.0k | 1.8k | 2.80 |
2020-06-30 | $16k | 5.3k | 3.04 |
2020-03-31 | $24k | 12k | 1.97 |
2019-12-31 | $23k | 8.0k | 2.86 |
2019-09-30 | $8.9k | 2.2k | 4.08 |
2019-06-30 | $37k | 9.0k | 4.11 |
2019-03-31 | $298k | 58k | 5.11 |
2015-12-31 | $2.0k | 1.3k | 1.51 |
2014-09-30 | $11k | 1.9k | 5.39 |
2014-03-31 | $7.0k | 431 | 16.24 |
2013-12-31 | $2.0k | 236 | 8.47 |